Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2027 Q1 | August 6, 2026 | — | 535.29M | — | 0.25 | — |
| 2026 Q4 | May 13, 2026 | 570.94M | 535.36M | 0.17 | 0.19 | — |
| 2026 Q3 | February 12, 2026 | 566.72M | 583.93M | 0.30 | 0.28 | — |
| 2026 Q2 | November 13, 2025 | 556.31M | 579.81M | 0.17 | 0.17 | — |
| 2026 Q1 | August 6, 2025 | 569.90M | 552.09M | 0.36 | — | — |
| 2025 Q4 | May 13, 2025 | 536.06M | 580.20M | 0.18 | 0.17 | — |
| 2025 Q3 | February 12, 2025 | 552.13M | 569.45M | 0.33 | 0.31 | — |
| 2025 Q2 | November 13, 2024 | 492.04M | 494.10M | 0.14 | 0.24 | — |
| 2025 Q1 | August 7, 2024 | 424.63M | 420.30M | 0.23 | 0.25 | — |
| 2024 Q4 | May 13, 2024 | 459.31M | 471.10M | 0.14 | 0.14 | — |
| 2024 Q3 | February 9, 2024 | 523.93M | 520.16M | 0.30 | 0.29 | — |
| 2024 Q2 | November 10, 2023 | — | — | — | — | — |
| 2024 Q1 | August 9, 2023 | — | — | — | — | — |
| 2023 Q4 | May 12, 2023 | — | — | — | — | — |
| 2023 Q3 | February 13, 2023 | 3.88M | 446.26M | 37.01 | 35.50 | — |
| 2023 Q2 | November 10, 2022 | 2.77M | 378.27M | 27.17 | 23.01 | — |